60 Participants Needed

Lower-body Negative Pressure Exercise for Heart Failure

SP
Overseen ByStephen P Wright, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of British Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The heart is a pump that must both fill and empty effectively to move blood; if it cannot move enough, heart failure may ensue. Approximately half of all adults living with heart failure have a form where the heart stiffens, which impairs its ability to fill. This form of heart failure particularly affects females and older adults. When people exercise, extra blood returns to the heart. The healthy heart can easily fill and move this extra blood to the muscles. However, when the heart's ability to fill is impaired, the extra blood can back up and pool in the lungs. Blood pooling in the lungs makes people feel breathless, although the investigators do not fully understand why, and this form of heart failure has a high risk of hospitalization and death, but few effective treatments are available. Exercise is one of the few treatments that works well if enough exercise is performed regularly. However, many people with this form of heart failure can only tolerate a small amount before stopping due to severe breathlessness, which can put them off from exercising regularly. The study's goal is to help these people perform more exercise. The investigators will use a novel form of stationary cycling with a plastic chamber around the lower body that seals at the waist. The chamber can apply suction to the lower body during exercise which will reduce how much extra blood returns and prevent the heart and lungs from being overloaded. Participants will attend 5 visits, including 3 where they will perform a submaximal exercise test for as many minutes as possible with or without light suction. In each of these tests, the investigators will record how long they exercise and ask them to rate how breathless they feel. The investigators will also study their breathing pattern, using a mouthpiece and pressure sensor, and heart function, using ultrasound imaging. This work will help adults living with heart failure exercise more and improve their health, and help researchers understand what causes breathlessness and develop new treatments.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, participants in the heart failure group must have been on stable medical therapy for at least 2 months before joining the study.

What data supports the effectiveness of the treatment Lower-body Negative Pressure Exercise for Heart Failure?

Exercise training has been shown to improve quality of life and exercise capacity in heart failure patients, with benefits such as better blood flow, improved muscle function, and reduced symptoms. Although the specific treatment of Lower-body Negative Pressure Exercise is not directly studied, similar exercise programs have demonstrated positive effects in heart failure management.12345

Is lower-body negative pressure exercise safe for humans?

Lower-body negative pressure (LBNP) has been used safely in research for decades, particularly in aerospace and military studies, to study blood pressure and cardiovascular responses. It is generally considered safe, though it can cause blood to pool in the lower body, which might lead to fainting in some cases.678910

How does the lower-body negative pressure exercise treatment for heart failure differ from other treatments?

Lower-body negative pressure exercise is unique because it combines physical exercise with a pressure change that mimics the effects of heart failure, potentially improving heart function by enhancing blood circulation and reducing fluid accumulation in the lower body, unlike traditional medications that primarily target heart rate or blood pressure.67111213

Research Team

ND

Neil D Eves, PhD

Principal Investigator

The University of British Columbia

Eligibility Criteria

This trial is for adults with a specific type of heart failure where the heart stiffens and has trouble filling (HFpEF). They should have had symptoms needing treatment in the past year, be somewhat active but not heavily exercising, and their condition should be stable. People can't join if they've had severe heart issues like low ejection fraction or certain diseases, are very overweight, smoke recently, or exercise a lot.

Inclusion Criteria

I have been treated for heart failure symptoms within the last year.
Your heart shows signs of being enlarged or not functioning properly based on specific measurements.
I have heart failure with preserved ejection fraction, mild to moderate symptoms, and have been stable on my current heart medication for at least 2 months.
See 3 more

Exclusion Criteria

The pressure in the vein in your neck is too high.
I use supplemental oxygen when I move around.
I have a significant heart condition.
See 12 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-2.5 hours
1 visit (in-person)

Baseline Testing

Enrolment, phenotyping, and baseline testing including anthropometrics, blood pressure, echocardiogram, pulmonary function tests, and an incremental cardiopulmonary exercise test

2-2.5 hours
1 visit (in-person)

Treatment

Participants undergo submaximal exercise with or without lower-body negative pressure, with assessments of ventilatory and cardiac function

3 visits, 1-1.5 hours each
3 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Lower-body Negative Pressure
  • Lower-body Neutral Pressure
Trial OverviewThe study tests whether using a special cycling machine that applies suction to the lower body helps people with HFpEF exercise more by preventing blood from pooling in their lungs. Participants will cycle under different pressure conditions to see how it affects breathlessness and exercise duration.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Heart Failure with Preserved Ejection Fraction (40 Participants)Experimental Treatment3 Interventions
Lower-body negative pressure (-15 and -25 mmHg) and neutral pressure (0 mmHg)
Group II: Healthy Controls (20 Participants)Active Control3 Interventions
Lower-body negative pressure (-15 and -25 mmHg) and neutral pressure (0 mmHg)

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of British Columbia

Lead Sponsor

Trials
1,506
Recruited
2,528,000+

Findings from Research

Exercise training in chronic heart failure patients has shown significant improvements in exercise capacity, comparable to the best pharmacological treatments, without deteriorating cardiac function.
Despite the lack of definitive evidence on improved survival rates, exercise training is recommended for selected heart failure patients, as it enhances muscle function, reduces ventilation during exercise, and improves overall quality of life when supervised properly.
[Physical activity and training in heart failure].Weber, T., Kirchgatterer, A., Auer, J., et al.[2019]
In a study of 27 elderly heart failure patients, both machine-assisted cycling and conventional exercise training improved exercise capacity equally, as measured by the 6-minute walk distance after 2 weeks.
Machine-assisted cycling showed a potential benefit in enhancing endothelial function, particularly in patients aged 80 and younger, suggesting it may be a more effective option for improving vascular health in this population.
Effects of machine-assisted cycling on exercise capacity and endothelial function in elderly patients with heart failure.Ozasa, N., Morimoto, T., Bao, B., et al.[2019]
Lower body positive pressure (LBPP) treadmill activity significantly increases left ventricular ejection duration (LVED) in both heart failure (HF) patients and healthy individuals, indicating potential benefits for heart function during exercise.
However, the increase in LVED is less pronounced in HF patients compared to healthy individuals, suggesting that while LBPP is beneficial, its effects may vary based on the patient's heart condition.
The Effect of Lower Body Positive Pressure on Left Ventricular Ejection Duration in Patients With Heart Failure.Avadhani, S., Ihsan, M., Nunez, A., et al.[2020]

References

Hemodynamic effects of exercise training in heart failure. [2011]
Effects of a home walking exercise program on functional status and symptoms in heart failure. [2007]
[Physical activity and training in heart failure]. [2019]
Exercise training in congestive heart failure. A review of the current status. [2007]
Effects of machine-assisted cycling on exercise capacity and endothelial function in elderly patients with heart failure. [2019]
Effects of selective angiotensin II and beta1-receptor blockade on renal haemodynamics and sodium handling during orthostatic stress in healthy individuals. [2021]
Dynamic leg exercise improves tolerance to lower body negative pressure. [2006]
[Effects of self-generated LBNP training on cardiovascular function and lower body negative pressure (LBNP) tolerance]. [2010]
Lower body negative pressure as a tool for research in aerospace physiology and military medicine. [2022]
10.Russia (Federation)pubmed.ncbi.nlm.nih.gov
[Hemodynamics of healthy persons under various regimens of negative pressure around the lower half of the body]. [2008]
Cardiac responses to lower body negative pressure and dynamic leg exercise. [2019]
12.United Statespubmed.ncbi.nlm.nih.gov
The Effect of Lower Body Positive Pressure on Left Ventricular Ejection Duration in Patients With Heart Failure. [2020]
13.United Statespubmed.ncbi.nlm.nih.gov
Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men. [2013]